Essex In the News

04/22/2014

Open Monoclonal Technology Provides Important Intellectual Property Update

04/21/2014

Revance Therapeutics Announces Positive Results From the RT002 Phase 1/2 Study Glabellar Frown Lines

03/19/2014

Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma PLC

02/07/2014

Revance Therapeutics Soars in Debut, While Egalet and Eleven Open Quietly

02/03/2014

Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million